首页> 外文OA文献 >Phase II study and biomarker analysis of cetuximab combined with modified FOLFOX6 in advanced gastric cancer

【2h】

Phase II study and biomarker analysis of cetuximab combined with modified FOLFOX6 in advanced gastric cancer

机译：西妥昔单抗联合改良FOLFOX6治疗晚期胃癌的II期研究和生物标志物分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Han, S-W; Oh, D-Y; Im, S-A; Park, S R; Lee, K-W; Song, H S; Lee, N-S; Lee, K H; Choi, I S; Lee, M H; Kim, M A; Kim, W H; Bang, Y-J; Kim, T-Y;
展开▼
作者单位

展开▼
年度 2009
总页数
原文格式 PDF
正文语种 {"code":"en","name":"English","id":9}
中图分类

相似文献

外文文献
中文文献
专利

1. Phase II study and biomarker analysis of cetuximab combined with modified FOLFOX6 in advanced gastric cancer [J] . S-W Han, D-Y Oh, S-A Im, British Journal of Cancer . 2009,第2期

机译：西妥昔单抗联合修饰的FOLFOX6治疗晚期胃癌的II期研究和生物标志物分析
2. A multi-center phase II study and biomarker analysis of combined cetuximab and modified FOLFIRI as second-line treatment in patients with metastatic gastric cancer [J] . Xin Liu, Weijian Guo, Wen Zhang, BMC Cancer . 2017,第1期

机译：西妥昔单抗联合改良FOLFIRI作为转移性胃癌患者二线治疗的多中心II期研究和生物标志物分析
3. A multi-center phase II study and biomarker analysis of combined cetuximab and modified FOLFIRI as second-line treatment in patients with metastatic gastric cancer [J] . Xin Liu, Weijian Guo, Wen Zhang, BMC Cancer . 2017,第1期

机译：西妥昔单抗联合改良FOLFIRI作为转移性胃癌患者二线治疗的多中心II期研究和生物标志物分析
4. Phase I/II clinical trials on the effect of weekly paclitaxel (wPTX) and wPTX containing combination regimens for advanced and metastatic gastric cancer -ECRIN group studies [C] . Sakamoto J, Kodera Y, Kobayashi M, International Gastric Cancer Congress . 2009

机译：I / II期临床试验关于每周紫杉醇（WPTX）和WPTX含有晚期和转移性胃癌组合方案的临床试验 - 分泌组研究
5. Equine Gastric Ulcers: A Pilot Study: Associated Biomarkers and Polysaccharide Supplementation as a Solution [D] . Svagerko, Peyton. 2021

机译：马胃溃疡：试点研究：相关的生物标志物和多糖补充作为溶液
6. Phase II study and biomarker analysis of cetuximab combined with modified FOLFOX6 in advanced gastric cancer [O] . S-W Han, D-Y Oh, S-A Im, 2009

机译：西妥昔单抗联合改良FOLFOX6治疗晚期胃癌的II期研究和生物标志物分析
7. A multi-center phase II study and biomarker analysis of combined cetuximab and modified FOLFIRI as second-line treatment in patients with metastatic gastric cancer [O] . 2017

机译：西妥昔单抗联合改良FOLFIRI作为转移性胃癌患者二线治疗的多中心II期研究和生物标志物分析

Phase II study and biomarker analysis of cetuximab combined with modified FOLFOX6 in advanced gastric cancer

著录项

相似文献

相关主题

期刊订阅